Product Code: ETC417022 | Publication Date: Oct 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Malaysia Buprenorphine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Starting at 0.02% in 2025, the market peaks at 0.03% in 2027, and settles at 0.02% by 2029.
By 2027, the Buprenorphine market in Malaysia is anticipated to reach a growth rate of 0.03%, as part of an increasingly competitive Asia region, where China remains at the forefront, supported by India, Japan, Australia and South Korea, driving innovations and market adoption across sectors.
Buprenorphine is a medication used in opioid addiction treatment. The market outlook is affected by factors such as healthcare policies, substance abuse rates, and availability of alternative treatments. Government initiatives and public health campaigns can also impact the demand for buprenorphine.
The buprenorphine market in Malaysia is influenced by the country`s efforts to combat the opioid crisis. Buprenorphine is used for opioid addiction treatment, and government initiatives to address substance abuse issues are leading to increased demand for this medication.
Buprenorphine is a medication used to treat opioid addiction. The market for buprenorphine in Malaysia has seen steady growth due to the increasing awareness of opioid addiction and the need for effective treatment options. Regulatory changes and efforts to combat addiction have also influenced this market positively.
The COVID-19 pandemic had a significant impact on the buprenorphine market in Malaysia. Due to lockdowns and restrictions, access to healthcare services was limited, leading to disruptions in the supply chain of buprenorphine products. This posed challenges for patients who rely on these medications for opioid addiction treatment. Additionally, the economic downturn caused by the pandemic led to financial constraints for some patients, affecting their ability to afford buprenorphine. However, as the healthcare system adapted to the new normal, telemedicine and online consultations became more prevalent, providing a lifeline for patients in need of buprenorphine treatment.
The buprenorphine market in Malaysia is anticipated to experience substantial growth, driven by its application in opioid addiction treatment. Major players in this market include Indivior PLC, Pfizer Inc., and Sanofi S.A.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Buprenorphine Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Buprenorphine Market - Industry Life Cycle |
3.4 Malaysia Buprenorphine Market - Porter's Five Forces |
3.5 Malaysia Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Malaysia Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Malaysia Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Malaysia Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about opioid addiction and the need for treatment options |
4.2.2 Growing government initiatives to address substance abuse issues |
4.2.3 Rise in the number of individuals seeking treatment for opioid dependence |
4.3 Market Restraints |
4.3.1 Stringent regulations and licensing requirements for buprenorphine prescribing |
4.3.2 Limited access to healthcare services in certain regions of Malaysia |
4.3.3 Stigma associated with medication-assisted treatment for opioid addiction |
5 Malaysia Buprenorphine Market Trends |
6 Malaysia Buprenorphine Market, By Types |
6.1 Malaysia Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Buprenorphine Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 Malaysia Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.4 Malaysia Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Malaysia Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Malaysia Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Malaysia Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Malaysia Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Malaysia Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Malaysia Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Malaysia Buprenorphine Market Import-Export Trade Statistics |
7.1 Malaysia Buprenorphine Market Export to Major Countries |
7.2 Malaysia Buprenorphine Market Imports from Major Countries |
8 Malaysia Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering buprenorphine treatment |
8.2 Percentage of healthcare professionals trained in prescribing buprenorphine |
8.3 Patient retention rate in buprenorphine treatment programs |
9 Malaysia Buprenorphine Market - Opportunity Assessment |
9.1 Malaysia Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Malaysia Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Malaysia Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Malaysia Buprenorphine Market - Competitive Landscape |
10.1 Malaysia Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |